Senior Medical Science Liaison

Responsibilities

• Identify, develop and maintain trusted relationships with KOLs, clinical investigators, and key stakeholders across academic and clinical psychiatry
• Serve as the primary medical resource in the field, delivering accurate and balanced scientific information
• Support scientific education at national and regional psychiatry conferences, advisory boards, and educational events
• Gather and communicate field insights to internal stakeholders to inform strategy
• Provide clinical and scientific input to cross-functional teams including R&D and Clinical Development
• Respond to unsolicited requests for medical information from healthcare professionals
• Support clinical teams with clinical trial site identification and enrollment initiatives
• Serve as a scientific expert for Government Affairs and HEOR in policy discussions and stakeholder briefings
• Partner with leadership to develop core training programs for future MSL onboarding
• Contribute to the design of field materials, medical decks, and engagement resources

Requirements

• Advanced scientific degree (PharmD, PhD, MD, or equivalent) strongly preferred
• Minimum of 5+ years of MSL or related medical affairs experience
• Required experience in psychiatry or CNS
• Proven record of supporting pre-launch through launch staged companies
• Deep understanding of psychiatric disease states and the U.S. healthcare landscape
• Strong presentation, communication, and interpersonal skills
• Ability to interpret and present complex scientific data
• Familiarity with CRM systems and compliant field operations
• Willingness to travel up to 60%

Preferred Qualifications

• Experience engaging with policy, government affairs, or advocacy stakeholders in the healthcare sector

Benefits

• 100% paid health benefits including Medical, Dental and Vision for you and your dependents
• 401(k) program with company match
• Flexible time off
• Generous parental leave

About the Company

Definium Therapeutics is a late-stage clinical biopharmaceutical company focused on applying scientific rigor to psychedelics to develop accessible treatments for psychiatric and neurological disorders.